1. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2;Rosenstein;Cancer Res.,1984
2. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose inter-leukin-2 alone;Rosenberg;N. Engl. J. Med.,1987
3. Recombinant IL-2-activated NK cells mediate LAK activity against ovarian cancer;Lotozová;Int. J. Cancer,1988
4. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages;Decker;J. Immunol,1987
5. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both;Ichinose;J. Immunol,1988